ATM

Biomarkers

ATM is involved in the following curated biomarkers.

Name	Biomarker type	Propositions	Statements
ATM pathogenic variants	Germline Variant	2	2
ATM oncogenic variants	Somatic Variant	2	2

Therapeutic response

Precision oncology relationships for therapeutic response involving this gene.

Organization(s)	Biomarker(s)	Cancer type	Therapy(ies)
FDA (1)	ATM pathogenic variants	Prostate Adenocarcinoma	Olaparib
FDA (1)	ATM pathogenic variants	Prostate Adenocarcinoma	Enzalutamide, Talazoparib
FDA (1)	ATM oncogenic variants	Prostate Adenocarcinoma	Olaparib
FDA (1)	ATM oncogenic variants	Prostate Adenocarcinoma	Enzalutamide, Talazoparib